952 results on '"Loren, Alison"'
Search Results
2. Evolving racial/ethnic disparities in AML survival in the novel therapy era
3. Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease
4. Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations
5. Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management
6. Driving distances and loss to follow-up after hematopoietic cell transplantation
7. Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors
8. Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis
9. Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia
10. The case for classical haematology: the impact of a name and the future of a field
11. Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
12. Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
13. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms
14. Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients
15. Who Enrolls in an Online Cancer Survivorship Program? Reach of the INSPIRE Randomized Controlled Trial for Hematopoietic Cell Transplantation Survivors
16. Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes
17. Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies
18. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
19. Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
20. Age and gender differences in financial distress among hematopoietic cell transplant survivors
21. Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation
22. Pulmonary Complications in Pediatric and Adolescent Patients Following Allogeneic Hematopoietic Cell Transplantation
23. Fertility preservation in patients with hematologic malignancies and recipients of hematopoietic cell transplants
24. Hematopoietic Cell Transplantation and Utilization of Fertility Preservation Services
25. Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial
26. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease
27. Fertility Preservation in Adolescents and Young Adults With Cancer: A Case-Based Review
28. Interim Results of a Phase I/II Trial of Intermediate-Dose Post-Transplantation Cyclophosphamide after Reduced Intensity Conditioned HLA-Mismatched Bone Marrow Transplantation for Older or Unfit Patients
29. Post-Transplant Frailty Phenotype Predicts Survival
30. One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
31. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases
32. Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation
33. Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors
34. Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant
35. Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation
36. Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors
37. Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants
38. Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation
39. Overview of Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies
40. Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation
41. Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
42. One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant
43. Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
44. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
45. Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay
46. Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation.
47. Patient-Centered Care in the Management of Cancer During Pregnancy
48. Supplemental Figure S1 from DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia
49. Supplemental Table S2 from DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia
50. Supplementary Table and Figure Legend from DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.